Status:
COMPLETED
Rectrospect - a Retrospective Study of Treatment Response
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Rectal Neoplasms
Eligibility:
All Genders
Brief Summary
Biopisies from patients diagnosed with rectal cancer between 2007-2019 will be cut into 4-6 micrometer thin sections for morphology and immunostaining. Every section will be numbered with a code that ...
Eligibility Criteria
Inclusion
- Rectal cancer and treatment between 2007 and 2019
Exclusion
- No rectal cancer or no neoadjuvant treatment
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04787523
Start Date
October 1 2020
End Date
December 31 2022
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, Sweden, SE 416 85